Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2021 Oct 17;28(1):32.e1–32.e10. doi: 10.1016/j.jtct.2021.10.010

Figure 4 –

Figure 4 –

(A) Total circulating dendritic cells, (B) plasmacytoid DCs, (C) myeloid DCs, (D) CD123−/CD11c− DCs (pembrolizumab vs control cohort). The interquartile range of healthy control patients for each cell population is depicted as a gray bar, and the median value is noted with a dashed line.